GeneDx Holdings CorpNASDAQ:WGS
- LAST PRICE11.0900
- TODAY'S CHANGE (%)-0.0800 (-0.7162%)
- Bid / Lots11.0900/ 2
- Ask / Lots11.1600/ 1
- Open / Previous Close11.2100 / 11.1700
- Day Range
- 52 Week Range
- Volume83,961
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | WGS |
|---|---|---|
| 09:32 ET | 1079 | 11.21 |
| 09:34 ET | 275 | 11.01 |
| 09:39 ET | 488 | 11.246 |
| 09:41 ET | 551 | 11.04 |
| 09:43 ET | 1300 | 11.075 |
| 09:45 ET | 300 | 11.14 |
| 09:48 ET | 500 | 11.125 |
| 09:50 ET | 600 | 11.11 |
| 09:54 ET | 1900 | 11.1 |
| 09:56 ET | 100 | 11.1 |
| 09:57 ET | 100 | 11.1 |
| 09:59 ET | 400 | 11.13 |
| 10:03 ET | 1080 | 11.12 |
| 10:06 ET | 385 | 11.14 |
| 10:08 ET | 900 | 11.09 |
| 10:10 ET | 1100 | 11.11 |
| 10:14 ET | 100 | 11.12 |
| 10:15 ET | 400 | 11.07 |
| 10:17 ET | 1175 | 11.12 |
| 10:19 ET | 150 | 11.115 |
| 10:21 ET | 2668 | 11 |
| 10:24 ET | 6054 | 10.98 |
| 10:26 ET | 1215 | 10.835 |
| 10:28 ET | 2438 | 10.91 |
| 10:32 ET | 718 | 10.97 |
| 10:33 ET | 400 | 11.01 |
| 10:44 ET | 100 | 11.03 |
| 10:46 ET | 633 | 10.97 |
| 10:55 ET | 100 | 10.92 |
| 11:02 ET | 500 | 11.05 |
| 11:11 ET | 700 | 10.93 |
| 11:20 ET | 218 | 10.965 |
| 11:24 ET | 565 | 11.04 |
| 11:26 ET | 3331 | 11.05 |
| 11:31 ET | 500 | 11 |
| 11:47 ET | 1050 | 11.11 |
| 11:49 ET | 1300 | 11.135 |
| 11:51 ET | 900 | 11.1 |
| 11:54 ET | 556 | 11.09 |
| 11:56 ET | 577 | 11.1 |
| 12:02 ET | 100 | 11.09 |
| 12:03 ET | 3200 | 11.09 |
| 12:05 ET | 463 | 11.115 |
| 12:07 ET | 100 | 11.13 |
| 12:16 ET | 400 | 11.14 |
| 12:18 ET | 300 | 11.155 |
| 12:21 ET | 775 | 11.12 |
| 12:23 ET | 700 | 11.08 |
| 12:25 ET | 1300 | 11.105 |
| 12:27 ET | 100 | 11.07 |
| 12:30 ET | 400 | 11.07 |
| 12:39 ET | 471 | 11.1002 |
| 12:50 ET | 100 | 11.11 |
| 12:54 ET | 100 | 11.08 |
| 12:56 ET | 1452 | 11.07 |
| 12:57 ET | 400 | 11.085 |
| 12:59 ET | 786 | 11.07 |
| 01:01 ET | 1700 | 11.075 |
| 01:08 ET | 2352 | 11.0707 |
| 01:10 ET | 100 | 11.02 |
| 01:15 ET | 6869 | 11.09 |
Apr 23, 2024
DJ GeneDx Shares Rise to 52-Week High After Komodo Health Partnership, from 11:08AM ET on Tuesday Apr 23, 2024 by Dow Jones
11:08AM ET on Tuesday Apr 23, 2024 by Dow JonesGeneDx Announces Partnership with Komodo Health to Expand Access to World's Largest Rare Disease Dataset, from 8:30AM ET on Tuesday Apr 23, 2024 by Dow Jones
8:30AM ET on Tuesday Apr 23, 2024 by Dow Jones
Apr 22, 2024
DJ GeneDx Holdings Is Maintained at Buy by BTIG, from 1:43PM ET on Monday Apr 22, 2024 by Dow Jones
1:43PM ET on Monday Apr 22, 2024 by Dow Jones
Apr 15, 2024
DJ GeneDx Holdings Is Maintained at Neutral by Goldman Sachs, from 10:34AM ET on Monday Apr 15, 2024 by Dow Jones
10:34AM ET on Monday Apr 15, 2024 by Dow Jones
Apr 4, 2024
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024, from 4:05PM ET on Thursday Apr 04, 2024 by Dow Jones
4:05PM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
GeneDx Holdings Corp | 291.0M | -1.5x | --- |
Viemed Healthcare Inc | 310.4M | 32.3x | +1.15% |
Airsculpt Technologies Inc | 317.6M | -71.5x | --- |
23andMe Holding Co. | 221.7M | -0.4x | --- |
Joint Corp | 180.4M | -18.3x | --- |
American Well Corp | 156.1M | -0.2x | --- |
Company Information
GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
Contact Information
- Headquarters
- 333 Ludlow Street North Tower, 8Th FloorSTAMFORD, CT, United States 06902
- Phone
- 617-780-8742
- Fax
- 302-655-5049
Executives
- Executive Chairman of the Board
- Jason Ryan
- Chief Executive Officer, Director
- Katherine Stueland
- Chief Financial Officer
- Kevin Feeley
- Chief Business Officer
- Kareem Saad
- Independent Director
- Eli Casdin
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $291.0M |
|---|---|
Revenue (TTM) | $202.6M |
Shares Outstanding | 26.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.62 |
EPS | $-7.51 |
Book Value | $8.78 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | 1.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -89.15% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
